Folgen
Li Tang (EPFL)
Titel
Zitiert von
Zitiert von
Jahr
Investigating the optimal size of anticancer nanomedicine
L Tang, X Yang, Q Yin, K Cai, H Wang, I Chaudhury, C Yao, Q Zhou, ...
Proceedings of the National Academy of Sciences 111 (43), 15344-15349, 2014
6712014
Nonporous silica nanoparticles for nanomedicine application
L Tang, J Cheng
Nano today 8 (3), 290-312, 2013
5982013
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
L Tang, Y Zheng, MB Melo, L Mabardi, AP Castaño, YQ Xie, N Li, ...
Nature biotechnology 36 (8), 707-716, 2018
5862018
Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion
YR Yu, H Imrichova, H Wang, T Chao, Z Xiao, M Gao, M Rincon-Restrepo, ...
Nature Immunology 21 (12), 1540-1551, 2020
3912020
Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions
A Mishra, GH Lai, NW Schmidt, VZ Sun, AR Rodriguez, R Tong, L Tang, ...
Proceedings of the National Academy of Sciences 108 (41), 16883-16888, 2011
3812011
Selective in vivo metabolic cell-labeling-mediated cancer targeting
H Wang, R Wang, K Cai, H He, Y Liu, J Yen, Z Wang, M Xu, Y Sun, ...
Nature chemical biology 13 (4), 415-424, 2017
3422017
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
Y Guo, YQ Xie, M Gao, Y Zhao, F Franco, M Wenes, I Siddiqui, ...
Nature Immunology 22 (6), 746-756, 2021
2802021
Synthesis and Biological Response of Size-Specific, Monodisperse Drug–Silica Nanoconjugates
L Tang, TM Fan, LB Borst, J Cheng
ACS nano 6 (5), 3954, 2012
2222012
Selective delivery of an anticancer drug with aptamer-functionalized liposomes to breast cancer cells in vitro and in vivo
H Xing, L Tang, X Yang, K Hwang, W Wang, Q Yin, NY Wong, ...
Journal of Materials Chemistry B 1 (39), 5288-5297, 2013
2162013
Smart chemistry in polymeric nanomedicine
R Tong, L Tang, L Ma, C Tu, R Baumgartner, J Cheng
Chemical Society Reviews 43 (20), 6982-7012, 2014
2062014
Size-dependent tumor penetration and in vivo efficacy of monodisperse drug-silica nanoconjugates
L Tang, NP Gabrielson, TM Fan, J Cheng
Molecular pharmaceutics, 2013
1932013
Redox-Responsive, Core-Cross-Linked Micelles Capable of On-Demand, Concurrent Drug Release and Structure Disassembly
H Wang, L Tang, C Tu, Z Song, Q Yin, L Yin, Z Zhang, J Cheng
Biomacromolecules 14 (10), 3706-3712, 2013
1862013
Biomaterial strategies for immunomodulation
NA Hotaling, L Tang, DJ Irvine, JE Babensee
Annual review of biomedical engineering 17 (1), 317-349, 2015
1832015
Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
Y Guo, K Lei, L Tang
Frontiers in Immunology 9, 1499, 2018
1672018
Central memory CD8+ T cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation
DP Ferreira, JG Silva, T Wyss, SAF Marraco, L Scarpellino, M Charmoy, ...
Immunity 53 (5), 985-1000. e11, 2020
1592020
Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy
K Lei, A Kurum, M Kaynak, L Bonati, Y Han, V Cencen, M Gao, YQ Xie, ...
Nature Biomedical Engineering 5 (12), 1411-1425, 2021
1572021
Enhancing adoptive cell therapy of cancer through targeted delivery of small-molecule immunomodulators to internalizing or noninternalizing receptors
Y Zheng, L Tang, L Mabardi, S Kumari, DJ Irvine
ACS nano 11 (3), 3089-3100, 2017
1492017
Chain‐Shattering Polymeric Therapeutics with On‐Demand Drug‐Release Capability
Y Zhang, Q Yin, L Yin, L Ma, L Tang, J Cheng
Angewandte Chemie International Edition 52 (25), 6435-6439, 2013
1492013
High-throughput quantitation of inorganic nanoparticle biodistribution at the single-cell level using mass cytometry
YSS Yang, PU Atukorale, KD Moynihan, A Bekdemir, K Rakhra, L Tang, ...
Nature communications 8 (1), 14069, 2017
1432017
Aptamer‐Functionalized, Ultra‐Small, Monodisperse Silica Nanoconjugates for Targeted Dual‐Modal Imaging of Lymph Nodes with Metastatic Tumors
L Tang, X Yang, LW Dobrucki, I Chaudhury, Q Yin, C Yao, S Lezmi, ...
Angewandte Chemie 124 (51), 12893-12898, 2012
1322012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20